Regulation of haematopoiesis by growth factors – emerging insights and therapies

Bibliography

• FUCHS E, SEGRE JA: Stem cells a new lease on life. Cell (2000) 100:143–155.
   PubMed Web of Science ®Google Scholar
• ZHU J, EMERSON S: Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene (2002) 21:3295–3313.
   PubMed Web of Science ®Google Scholar
• OSAWA M, HANADA K, HAMADA H, NAKAUCHI H: Long-term lymphohematopoietic reconstitution by asingle CD34-low/negative hematopoietic stem cell. Science (1996) 273:242–245.
   PubMed Web of Science ®Google Scholar
• BJORNSON CR, RIETZE RL, REYNOLDS BA, MAGLI MC, VESCOVI AL: Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science (1999) 283:534–537.
   PubMed Web of Science ®Google Scholar
• BRAZELTON TR, ROSSI FM, KESHET GI, BLAU HM: From marrow to brain: expression of neuronal phenotypes in adult mice. (2000) Science 290:1775–1779.
   Google Scholar
• IVANOVA NB, DIMOS JT, SCHANIEL C et al.: A stem cell molecular signature. Science (2002) 298:601–604.
   PubMed Web of Science ®Google Scholar
• OGAWA M: Differentiation and proliferation of hematopoietic stem cells. Blood(1993) 81:2844–2853.
   PubMed Web of Science ®Google Scholar
• LEMISCHKA IR: Microenvironmental regulation of hematopoieic stem cells. Stem Cells (1997) 15\(Suppl. 1):63–69.
   Google Scholar
• MONTECINO-RODRIGUEZ E, DORSHKIND K: Regulation of hematopoiesis by gap junction-mediated intercellular communication. Leukoc. Biol. (2001) 70:341–347.
   PubMed Web of Science ®Google Scholar
• HESISSIG B, HATTORI K, DIAS S et al:Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-Ligand. Cell (2002) 109:625–637.
   PubMed Web of Science ®Google Scholar
• PELUS LM, BIAN H, KING AG, FUFUDA S: Neutrophil-derived MMP-9 mediates synergistic mobilisation of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GROP/CCXCL2 and GROW CXCL2delta4. Blood (2004) 103:110–119.
   PubMed Web of Science ®Google Scholar
• KARANU FN, MURDOCH B, GALLACHER L et al.: The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. Exp. Med. (2000) 192:1365–1372.
   PubMed Web of Science ®Google Scholar
• BIGAS A, MARTIN DIK, MILNER LA:Notchl and Notch2 inhibit myeloid differentiation in response to different cytokines. Ma Cell. Biol (1998) 18:2324–2333.
   Web of Science ®Google Scholar
• LAM LT, RONCHINI C, NORTON J et al.: Suppression of erythroid but not megakaryocytic differentiation of human K562 erythroleukemic cells by notch-1. J. Biol. Chem. (2000) 275:19676–19684.
   PubMed Web of Science ®Google Scholar
• KRAUSE DS: Regulation of hematopoieticstem cell fate. Oncogene (2002) 21:3262–3269.
   PubMed Web of Science ®Google Scholar
• BIGAS A, MILNER LA: Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. Blood (1999) 93:2431–2448.
   PubMed Web of Science ®Google Scholar
• INGLES-ESTEVE J, ESPINOSA L, MILNER LA, CAELLES C, BIHAS A: Phosphorylation of Ser2078 modulates the Notch2 function in 32D cell differentiation. Biol. Chem. (2001) 276:44873–44880.
   Web of Science ®Google Scholar
• CALVI LM, ADAMS GB, WELBRECHT KW et al.: Osteoblastic cells regulate the haematopoietic stem cell niche. Nature (2003) 425:841–846.
   PubMed Web of Science ®Google Scholar
• MARTIN C, BRUDON PC, BRIDGER G et al.: Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity (2003) 19:583–593.
   PubMed Web of Science ®Google Scholar
• LEVESQUE JP, HENDY J, TAKAMATSU Y et al.: Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCS or cyclophosphamide. Clin. Invest. (2003) 111:187–196.
   Google Scholar
• SEMERAD CL, LIU F, GREGORY AD et al.: G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity (2002) 17:413–423.
   PubMed Web of Science ®Google Scholar
• PELUS LM, BIAN H, KING AG, FUKUDA S: Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GROP/CXCL2 and GROPT/ CXCL244. Blood (2004) 103 (1):110–119.
   PubMed Web of Science ®Google Scholar
• LEVESQUE JP, HENDYJ, WINKLER IGet al.: Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD 117) from the surface of hematopoietic progenitor cells. Exp. Hematol. (2003) 31:109–117.
   Google Scholar
• LEVESQUE JP, HENDY J, TAKAMATSU Y et al.: Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp. Hematol. (2002) 30:440–449.
   PubMed Web of Science ®Google Scholar
• LI MO, SARKISIAN MR, MEHAL WZ, RAKIC P, FLAVELL RA: Phosphatidylserine receptor is required for clearance of apoptotic cells. Science (2003) 302:1560–1563.
   PubMed Web of Science ®Google Scholar
• ROVERE P, PERI G, FAZZINI F et al.: The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood (2000) 96:4300–4306.
   PubMed Web of Science ®Google Scholar
• BURNS AR, BOWDEN RA, MACDONELL SD et al.: Analysis of tight junctions during neutrophil transendothelial migration. I Cell Sci. (2000) 113:45–57.
   PubMed Web of Science ®Google Scholar
• BURNS AR, WALKER DC, BROWN ES et al.: Neutrophil transendothelial migration is independent of tight junctions and occurs preferentially at tricellular corners. Immunol. (1997) 159:2893–2903.
   Web of Science ®Google Scholar
• STEIN BN, GAMBLE JR, PITSON SM, VADAS MA, KHEW-GOODALL Y: Activation of endothelial extracellular signal-regulated kinase is essential for neutrophil transmigration: potential involvement of a soluble neutrophil factor in endothelial activation.' Immunol. (2003) 171(11):6097–6104.
   Web of Science ®Google Scholar
• YAMAMOTO H, SEDGWICK JB, VRTIS RF, BUSSE WW: The effect of transendothelial migration on eosinophil function. Am.). Respir. Cell Mol. Biol. (2000) 23:379–388.
   PubMed Web of Science ®Google Scholar
• MULLER WA, RANDOLPH GJ: Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. Leukoc. Biol. (1999) 66:698–704.
   PubMed Web of Science ®Google Scholar
• OTTONELLO L, CUTOLO M, FRUMENTO G et al.: Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: role of adenosine and proinflammatory cytokines. Rheumatology (Oxford) (2002) 41:1249–1260.
   PubMed Web of Science ®Google Scholar
• GUTHRIDGE MA, STOMSKI FC, THOMAS D et al.: Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors. Stem Cells (1998) 16:301–313.
   PubMed Web of Science ®Google Scholar
• LOTEM J, SACHS L: Cytokine control of developmental programs in normal hematopoiesis and leukemia. Oncogene (2002) 21:3284–3294.
   PubMed Web of Science ®Google Scholar
• HAMILTON JA: GM-CSF in inflammation and autoimmunity. Trends Immunol. (2002) 23:403–408.
   PubMed Web of Science ®Google Scholar
• VAN LEEUWEN BH, MARTINSON ME, WEBB GC, YOUNG IG: Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5. Blood (1989) 73:1142–1148.
   PubMed Web of Science ®Google Scholar
• OGAWA M: Differentiation and proliferation of hematopoietic stem cells. Blood(1993) 81:2844–2853.
   PubMed Web of Science ®Google Scholar
• BROUDY VC: Stem cell factor and hematopoiesis. Blood (1997) 90:1345–1364.
   PubMed Web of Science ®Google Scholar
• RYFFEL B, MIHATSCH MJ, WOERLY G: Pathology induced by interleukin-6. Int. Rev Exp. Pathol. (1993) 34:79–89.
   PubMedGoogle Scholar
• ISHIBASHI T, KIMURA H, UCHIDA T et al.: Human interleukin 6 is a direct promoter for maturation of megakaryocytes in vitro. Proc. Nati Acad. Sci. USA (1989) 86:5953–5957.
   PubMed Web of Science ®Google Scholar
• ROBB L, DRINKWATER CC, METCALF D et al.: Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc. Nati Acad. Sci. USA (1995) 92:9565–9569.
   PubMed Web of Science ®Google Scholar
• SCHEDING S, BERGMANN M, SHIMOSAKA A, WOLFF Pet al.: Human plasma thrombopoietin levels are regulated by binding to platelet thrombopoietin receptors M vivo. Transfusion (2002) 42:321–328.
   Google Scholar
• SMITH MA, COURT EL, SMITH JG: Stem cell factor: laboratory and clinical aspects. Blood Rev (2001) 15:191–197.
   PubMed Web of Science ®Google Scholar
• MIYAZAWA K, WILLIAMS DA, GOTOH A, NISHIMAKI J, BROXMEYER HE, TOYAMA K: Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. Blood (1995) 85:641–649.
   PubMed Web of Science ®Google Scholar
• SLATER NJ, YAMAGUCHI M, ROTH WELL DG, BAKER P, HEYVVORTH CM, CHOPRA R: The human granulocyte/macrophage colony-stimulating factor receptor alpha2 isoform influences haemopoietic lineage commitment and divergence. Br. Haematoi (2003) 122:150–158.
   PubMed Web of Science ®Google Scholar
• GALE RE, FREEBURN RW, KHWAJA A, CHOPRA R, LINCH DC: A truncated isoform of the human beta chain common to the receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 with increased mRNA expression in some patients with acute leukemia. Blood (1998) 91:54–63.
   PubMed Web of Science ®Google Scholar
• HEANEY ML, VERA JC, RAINES MA,GOLDE DW: Membrane-associated and soluble granulocyte/macrophage-colony-stimulating factor receptor alpha subunits are independently regulated in HL-60 cells. Proc. Natl. Acad. Sci. USA (1995) 92:2365–2369.
   PubMed Web of Science ®Google Scholar
• YANG FC, WATANABE S, TSUJI K et al.:Human granulocyte colony-stimulating factor (G-CSF) stimulates the M vitro and in vivo development but not commitment of primitive multipotential progenitors from transgenic mice expressing the human G-CSF receptor. Blood (1998) 92:4632–4640.
   PubMed Web of Science ®Google Scholar
• LAGASSE E, WEISSMAN IL: Enforced expression of Bc1-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell (1997) 89:1021–1031.
   PubMed Web of Science ®Google Scholar
• KONDO M, SCHERER DC, MIYAMOTO T et al.: Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature (2000) 407:383–386.
   PubMed Web of Science ®Google Scholar
• IWASAKI-ARAI J, IWASAKI H, MIYAMOTO T, WATANABE S, AKASHI K: Enforced granulocyte/ macrophage colony stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion. Exp. Med. (2003) 10:1311–1322.
   Web of Science ®Google Scholar
• EVANS CA, PIERCE A, WINTERS et al.:Activation of granulocyte-macrophage colony-stimulating factor and interlekin-3 receptor subunits in a multipotential hematopoietic progenitor cell line leads to differential effects on development. Blood (1999) 94:1504–1514.
   PubMed Web of Science ®Google Scholar
• EVANS CA, ARIFFIN S, PIERCE A, WHETTON AD: Identification of primary structural features that define the differential actions of IL-3 and GM-CSF receptors. Blood (2002) 100:3164–3174.
   PubMed Web of Science ®Google Scholar
• SCHMID I, BALDWIN GC, JACOBS EL et al.: Alterations in phenotype and cell-surface antigen expression levels of human monocytes: differential response to in vivo administration of rhM-CSF or rhGM-CSF. Cytometry (1995) 22:103–110.
   PubMedGoogle Scholar
• CHAPUIS F, ROSENZWAJG M, YAGELLO M, EKMAN M, BIBERFELD P, GLUCKMAN JC: Differentiation of human dendritic cells from monocytes M vitro. Ear: Immunol. (1997) 27:431–441.
   PubMed Web of Science ®Google Scholar
• STANLEY E, LIES CHKE GJ, GRAIL Det al.: Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA (1994) 91:5592–5596.
   Google Scholar
• SHIBATA Y, BERCLAZ PY, CHRONEOS ZC, YOSHIDA M, WHITSETT JA, TRAPNELL BC: GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity (2001) 15:557–567.
   Google Scholar
• ENZLER T, GILLESSEN S, MANIS JP et al.: Deficiencies of GM-CSF and interferon gamma link inflammation and cancer. J. Exp. Med (2003) 197:1213–1219.
   PubMed Web of Science ®Google Scholar
• METCALF D, NICOLA NA, GOUGH NM, ELLIOTT M, MCARTHUR G, LI M: Synergistic suppression: anomalous inhibition of the proliferation of factor-dependent hemopoietic cells by combination of two colony-stimulating factors. Proc. Natl. Acad. Sci. USA (1992) 89:2819–2823.
   PubMed Web of Science ®Google Scholar
• GEISSMANN F, JUNG S, LITTMAN DR: Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity (2003) 19:71–82.
   PubMed Web of Science ®Google Scholar
• FORTUNEL NO, HATZFELD JA, MONIER MN, HATZFELD A: Control of hematopoietic stem/progenitor cell fate by transforming growth factor-beta. Oncol. Res. (2003)13:445–453.
   PubMed Web of Science ®Google Scholar
• LE Y, MURPHY PM, WANG JM: Formyl-peptide receptors revisited. Trends Immunol. (2002) 23:541–548.
   PubMed Web of Science ®Google Scholar
• SUENOBU S, TAKAKURA N, INADA T et al.: A role of EphB4 receptor and its ligand, ephrin-B2, in erythropoiesis. Biochem. Biophys. Res. Commun. (2002) 293:1124–1131.
   PubMed Web of Science ®Google Scholar
• DEMIROGLU H: Postrenal transplant erythrocytosis: the roles of testosterone and erythropoietin. Clin. Nephroi (1997) 47:279.
   PubMed Web of Science ®Google Scholar
• SCHLESSINGER J: Cell signalling by receptor tyrosine kinases. Cell (2000) 103:211–225.
   PubMed Web of Science ®Google Scholar
• HERCUS TR, BAGLEY CJ, CAMBARERI B et al.: Specific human granulocyte-macrophage colony-stimulating factor antagonists. Proc. Natl. Acad. Sci. USA (1994) 91:5838–5842.
   PubMed Web of Science ®Google Scholar
• MCCLURE BJ, HERCUS TR, CAMBARERI BA et al.: Molecular assembly of the ternary granulocyte-macrophage colony-stimulating factor receptor complex. Blood (2003) 101:1308–1315.
   PubMed Web of Science ®Google Scholar
• SPORENO E, SAVINO R, CIAPPONI L et al.: Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells. Blood (1996) 87:4510–4519.
   PubMed Web of Science ®Google Scholar
• BOULANGER MJ, CHOW DC, BREVNOVA EE, GARCIA KC: Hexameric structure and assembly of the interleukin-6/ IL-6 alpha-receptor/gp130 complex. Science (2003) 300:2101–2104.
   PubMed Web of Science ®Google Scholar
• KORPELAINEN El, GAMBLE JR, VADAS MA, LOPEZ AF: IL-3 receptor expression, regulation and function in cells of the vasculature. Immunol. Cell Biol. (1996) 74:1–7.
   PubMed Web of Science ®Google Scholar
• STOMSKI FC, DOTTORE M, WINNALL W et al.: Identification of a 14-3-3 binding sequence in the common beta chain of the granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 receptors that is serine-phosphorylated by GM-CSF. Blood (1999) 94(6):1933–1942.
   PubMed Web of Science ®Google Scholar
• GUTHRIDGE MA, STOMSKI FC, BARRY EF et al.: Site-specific serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival. MoL Cell(2000) 6:99–108.
   PubMed Web of Science ®Google Scholar
• VAUDRY D, STORK PJ, LAZAROVICI P,EIDEN LE: Signaling pathways for PC12 cell differentiation: making the right connections. Science (2002) 296: 1648-1649.
   Google Scholar
• METCALF D, BEGLEY CG, JOHNSON GR et al.: Biologic properties M vitro of a recombinant human granulocyte-macrophage colony-stimulating factor. Blood (1986) 67:37–45.
   PubMed Web of Science ®Google Scholar
• NEMUNAITIS J, SHANNON-DORCY K, APPELBAUM FR et al.: Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. Blood (1993) 82:1422–1427.
   PubMed Web of Science ®Google Scholar
• BLAISE D, FAUCHER C, VEY N, CARAUX J, MARACHINI D, CHABANNON C: Rescue of haematopoiesis by a combination of growth factors including stem cell factor. Lancet (2000) 356:1325–1326.
   PubMed Web of Science ®Google Scholar
• CANTOR SB, ELTING LS, HUDSON DV JR, RUBENSTEIN EB: Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy. Cancer (2003) 97:3099–3106.
   PubMed Web of Science ®Google Scholar
• ELLIS M, ZWAAN F, HEDSTROM U et al.: Recombinant human interleukin 11 and bacterial infection in patients with correction of haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. Lancet (2003) 361:275–280.
   PubMed Web of Science ®Google Scholar
• BASSER RL, RASKO JE, CLARKE K et al.: Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. Lancet (1996) 348:1279–1281.
   PubMed Web of Science ®Google Scholar
• KUTER DJ, BEGLEY CG: Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Blood (2002) 100:3457–3469.
   PubMed Web of Science ®Google Scholar
• JOHNSON DL, FARRELL FX, BARBONE FP et al.: Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMPl. Biochemistry (1998) 37:3699–3710.
   PubMed Web of Science ®Google Scholar
• TIAN SS, LAMB P, KING AG et al.:A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor. Science (1998) 281:257–259.
   PubMed Web of Science ®Google Scholar
• KUSANO K, EBARA S, TACHIBANA K et al.: Potential therapeutic role for small nonpeptidyl compounds that mimic human granulocyte colony-stimulating factor. Blood (2004) 103(3):836–842.
   PubMed Web of Science ®Google Scholar
• PETRUCCI M, RICCIARDI MR, GREGORJ C et al: Effects of IL-6 variants in multiple myeloma: growth inhibition and induction of apoptosis in primary cells. Leak. Lymphoma (2002) 43:2369–2375.
   PubMed Web of Science ®Google Scholar
• COOK AD, BRAINE EL, CAMPBELL IK, RICH MJ, HAMILTON JA: Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritic Res. (2001) 3:293–298.
   PubMedGoogle Scholar
• KITCHING AR, RU HUANG X, TURNER AL, TIPPING PG, DUNN AR, HOLDSWORTH SR: The requirement for granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in leukocyte-mediated immune glomerular injury. I Am. Soc. Nephrol. (2002) 13:350–358.
   PubMed Web of Science ®Google Scholar
• MCQUALTERJL, DARWICHE R, EWING C et al.: Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. Exp. Med. (2001) 194:873–882.
   PubMed Web of Science ®Google Scholar
• CAMPBELL IK, O& DONNELL K, LAWLOR KE, WICKS IP: Severe inflammatory arthritis and lymphadenopathy in the absence of TNF. Clin. Invest. (2001) 107:1519–1527.
   Google Scholar
• BERNARD F, THOMAS C, EMILE JF et al.: Transient hematologic and clinical effect of E21R in a child with end-stage juvenile myelomonocytic leukemia. Blood (2002) 99:2615–2616.
   PubMed Web of Science ®Google Scholar
• SUN Q, JONES K, MCCLURE B: Simultaneous antagonism of interleukin-5, granulocyte-macrophage colony-stimulating factor, and interleukin-3 stimulation of human eosinophils by targetting the common cytokine binding site of their receptors. Blood (1999) 94: 1943-1951.
   Google Scholar
• RAMSHAW HS, WOODCOCK JM, BAGLEY CJ, MCCLURE BJ, HERCUS TR, LOPEZ AF: New approaches in the treatment of asthma. Immunol Cell Biol. (2001) 79:154–159.
   PubMed Web of Science ®Google Scholar